Enalare Therapeutics

United States
Florida, Naples, United States

Company profile

Enalare Therapeutics company profile

Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from acute respiratory and critical care conditions including respiratory depression caused by drug overdose, post-surgery, and pathogens.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2019-01-01

Headquarters

Headquarters
Florida, Naples, United States
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
8
Total equity funding
$22.5M
Last funding
Grant / $2.5M / 2025-01-30
Last equity funding
Corporate Round / $12.5M
Investors
4
Lead investors
4
Founders
1
Articles
22

Founders and investors

Founders

Joseph Pergolizzi

Lead investors

Biomedical Advanced Research and Development Authority (BARDA)Eagle PharmaceuticalsNational Institute on Drug Abuse (NIDA)NJEDA

Investors

Biomedical Advanced Research and Development Authority (BARDA)Eagle PharmaceuticalsNational Institute on Drug Abuse (NIDA)NJEDA

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.